Las Vegas, NV, October 02, 2015 --(PR.com
)-- Altogen Biosystems has exclusively developed a highly effective In Vivo Polymer Transfection Kit that is capable of delivering siRNA, mRNA, small proteins, and DNA into various rodent tissues for pre-clinical and laboratory research. The efficacy of the Altogen Biosystems new in vivo transfection reagent is based upon the science of biodegradable polymers. Amphiphilic copolymers are used as gene carriers where negatively charged cargo molecules (siRNA, mRNA, small protein or DNA) binds to the polycation through ionic interactions and polymers condense complex into sub-150-nm particles.
As with all of the kits that Altogen Biosystems has developed, the In Vivo Polymer Kit includes a pre-optimized protocol in order to streamline research and ensure quality results. Altogen Biosystems has developed one of the few kits that is proven to be effective, providing the diversity for target tissues. The In Vivo Polymer Kit allows for transfection to brain, liver, pancreas, tumor, kidney, heart and lung tissues that can be used in biomedical research and oncology applications.
The kit has been functionally tested in rats and mice and allows for intravenous, intraperitoneal as well as subcutaneous intratumoral modes of administration. Additionally, the use of biodegradable polymers were designed to minimize toxicity and as a result there is no inflammatory response associated with transfection. According to transfection protocol the “hands-on” time for this kit is thirty minutes or less.
Read more about a Polymer Based In Vivo Transfection Kit at http://www.altogen.com/polymer-based-in-vivo-transfection-reagent.php.
As a leading provider of preclinical biology research products and services (offered by Altogen Labs), Altogen Biosystems (www.altogen.com) ensures quality of all Altogen® In Vivo products.
Source: Altogen Biosystems, 848 Rainbow Blvd #823, Las Vegas, NV 89107. Tel: (702) 349-6103. Fax: (702) 989-0841. E-mail: email@example.com